Conmed Corp (NYSE: CNMD) on Friday, soared 2.46% from the previous trading day, before settling in for the closing price of $39.85. Within the past 52 weeks, CNMD’s price has moved between $38.32 and $74.75.
A company in the Healthcare sector has jumped its sales by 34.38% annually for the last half of the decade. The company achieved an average annual earnings per share of 7.95%. With a float of $30.02 million, this company’s outstanding shares have now reached $30.96 million.
Conmed Corp (CNMD) Insider and Institutional Ownership
Observing investor behavior towards Medical Devices industry stocks is more important than anything else. The insider ownership of Conmed Corp is 3.05%, while institutional ownership is 109.70%. The most recent insider transaction that took place on Nov 21 ’25, was worth 10,591. In this transaction Chief Information Officer of this company sold 257 shares at a rate of $41.21, taking the stock ownership to the 0 shares. Before that another transaction happened on Nov 21 ’25, when Company’s Officer proposed sale 257 for $41.21, making the entire transaction worth $10,591.
Conmed Corp (CNMD) Latest Financial update
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported 1.34 earnings per share (EPS) for the period topping the consensus outlook (set at 1.2) by 0.14. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.95 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 7.95% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 7.28% during the next five years compared to 34.38% growth over the previous five years of trading.
Conmed Corp (NYSE: CNMD) Trading Performance Indicators
Conmed Corp (CNMD) is currently performing well based on its current performance indicators. A quick ratio of 0.95 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.94. Likewise, its price to free cash flow for the trailing twelve months is 8.49.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 2.06, a number that is poised to hit 1.32 in the next quarter and is forecasted to reach 4.54 in one year’s time.
Technical Analysis of Conmed Corp (CNMD)
Let’s dig in a bit further. During the last 5-days, its volume was 0.73 million. That was better than the volume of 0.47 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 22.99%.
During the past 100 days, Conmed Corp’s (CNMD) raw stochastic average was set at 13.70%, which indicates a significant decrease from 34.86% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.67 in the past 14 days, which was lower than the 1.68 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $44.14, while its 200-day Moving Average is $51.68. However, in the short run, Conmed Corp’s stock first resistance to watch stands at $41.49. Second resistance stands at $42.15. The third major resistance level sits at $43.14. If the price goes on to break the first support level at $39.84, it is likely to go to the next support level at $38.85. The third support level lies at $38.19 if the price breaches the second support level.
Conmed Corp (NYSE: CNMD) Key Stats
Market capitalization of the company is 1.26 billion based on 30,968K outstanding shares. Right now, sales total 1,307 M and income totals 132,420 K. The company made 337,930 K in profit during its latest quarter, and 2,860 K in sales during its previous quarter.
